BD PROJECTS

• Request for Product

  TOP10 MNC Seeking FIC or BIC Products: Asthma

  2024年6月6日
• Insights

  【ASCO Highlights】China-made First-in-Class Claudin 18.2 CAR-T Therapy Shows Promising Phase I Results!

  2024年6月6日
• Insights

  Is it too early for Akeso and Summit to celebrate? Merck executive comments on the explosive news that Keytruda has been successfully challenged

  2024年6月5日
• Insights

  After ten years, Merck returns to the field of ophthalmology with a $3 billion investment!

  2024年6月4日
• Request for Product

  TOP10 MNC Seeking FIC or BIC Products: Inflammatory bowel disease (IBD)

  2024年6月4日
• Bio News

  Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290

  2024年6月4日
• Bio News

  Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC

  2024年6月3日
• Insights

  ASCO Express: From “low expression” to “even lower expression”, the best-selling ADC enters the next level!

  2024年6月3日
• Request for Product

  Are you looking for a promising product to license in? We can help you, and completely free of charge!

  2024年6月3日
• Product for Licensing

  Do you have a promising product to license out? We can help you!

  2024年6月3日